• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXAL085902E
Device Problem Obstruction of Flow (2423)
Patient Problems Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
Event Date 07/27/2021
Event Type  Injury  
Manufacturer Narrative
Patient identifier: no patient specific details have been provided.Therefore, the patient initials reflect the study number with codes for the hospital and patient.Other code: as the device remains implanted, no further investigation can be performed.No clinical images enabling direct assessment of product performance were returned for evaluation.(b)(4).In the instruction for use for the gore® viabahn® vbx balloon expandable endoprosthesis the following is stated: adverse events: potential clinical and device adverse events: possible adverse events and complications that may occur with the use of this device or in any endovascular procedure and require intervention include, but are not limited to: occlusion (thrombosis and/or stenosis) of endoprosthesis or vessel heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on (b)(6) 2021, the patient underwent endovascular treatment for a thoraco-abdominal aneurysm type ii (dissection) in the descending thoracic aorta.As fenestrated and branched graft a cook custom graft was used and an abdominal aortic stent graft component.As external branches a gore® viabahn® vbx balloon expandable endoprosthesis (vbx-device) was implanted in the celiac trunk, one vbx-device in the superior mesenteric artery, two vbx-devices and one bare metal stent in the right renal artery and one vbx-device and one vsx-device in the left renal artery.The devices were implanted successfully and were patent at the end of the procedure.At discharge single antiplatelet therapy and the use of anticoagulant, namely vitamin k antagonist was prescribed.During a follow-up visit on (b)(6) 2021, imaging was performed (cta), which indicated occlusion of the celiac trunk and the right renal artery.This patient is extreme anxious about his status.An outside hospital informed the physician who has conducted the branched endovascular aortic repair (bevar) about the occlusions, and he offered him admission and thrombolysis with a discussion of prognosis and risks.As he was clinically unaffected by the occlusions and would like to have as little to do with further surgeries as possible, he refused this offer of treatment.No reinterventions have occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16119975
MDR Text Key306880513
Report Number2017233-2023-03629
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeDA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 01/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/30/2023
Device Catalogue NumberBXAL085902E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/31/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COOK CUSTOM GRAFT, BARE METAL STENT, VSX-DEVICE
Patient Outcome(s) Other;
Patient Age28 YR
Patient SexMale
-
-